Hints and tips:
Related Special Reports
...Last year, Richard and his wife Amanda relocated to Cambridge when she got a job with a biotech company in one of the city’s science parks....
...Paul Weiss has hired Clifford Chance London-based private equity partners Chris Sullivan and Taner Hassan, Financial News reports....
...The presidents of the Atlanta, Richmond and St Louis Fed branches will also speak at public events....
...Paul McKinnon, former head of human resources at Citi, sat a few doors down from Fraser in her first few years at the bank....
...This high cash burn rate is out of step with the market environment following the biotech crash and could pose unintended consequences for Grail following a divestment, he said....
...FTSE 100 wealth manager St James’s Place’s business model is coming under scrutiny....
...On Friday, Lyons will formally take over at an event called the “silent ceremony” before the City’s annual lord mayor’s show on Saturday, at which he will swear his allegiance to King Charles at St Paul’...
...It’s all very colourful though. 5) Fern Labs Inc ($1mn for 5 per cent stake) There’s a company called Fern Labs Inc based at 280 Smith St, Farmingdale, NY 11735, United States, roughly in the middle of...
...I started last week navigating trains in the south of England en route to the Amex Stadium, home of English Premier League club Brighton & Hove Albion to meet chief executive Paul Barber for an upcoming...
...“The shock on the market is less than expected,” said Paul Choi, head of research at brokerage CLSA in Seoul....
...“It’s a Cinderella story,” said Stacey Schultz-Cherry, an infectious disease specialist at St Jude’s Children’s Research Hospital in Tennessee....
...At the end of the year, external winners are due, pandemic willing, to be rewarded with a tour of the FT offices near St Paul’s Cathedral in London....
...who stands to make $56m from a golden parachute clause if he leaves following the deal’s completion, according to FT calculations; Elliott Management after the London office of the hedge fund headed by Paul...
...Sanofi plans to sell down most of its 20.6 per cent stake in US biotech Regeneron as part of chief executive Paul Hudson’s promised overhaul of the French pharmaceutical maker....
...All 139 companies, which also include Superdrug, St Johnstone Football Club and Müller UK, have been forced to pay back wages to their workers....
...CanSino Biologics, the Chinese biotech, has tested its potential vaccine in a single dose — but is now starting a two-dose trial....
...Two other vaccines, one developed by Oxford university and AstraZeneca, and another from the US biotech Moderna, have also proved effective in late stage trials....
...Now Mancunian boss Paul Hudson is getting firepower of his own. The French company plans to sell most of its $13bn stake in US biotech Regeneron....
...The $40bn-in-assets hedge fund, which is run by founder Paul Singer, first built a stake in Alexion in 2017 but has not disclosed its exact size....
...In December, the company purchased Synthorx, a California biotech group, for $2.5bn. Sanofi will continue to work with Regeneron after the sale....
...Unveiling the strategic shift, Paul Hudson, chief executive, targeted €2bn in efficiency savings by 2022 and announced that its consumer healthcare division would become a standalone business as he gave...
...Solomon was previously general counsel at the biotech start-up Velocity Sciences and Samadi joins from Milbank....
...Paul Stoffels, chief scientific officer at Johnson & Johnson, says one of the biggest questions is whether it will stop infection or just the disease — or even, like the flu shot, only prevent the most severe...
...“We have outperformed the market in a spectacular way,” said L’Oréal’s chief executive Jean-Paul Agon. “This confirms that our strategy to focus on Asia, skincare, and luxury has paid off.”...
...Academics at the University of Alabama in Tuscaloosa, US, and St Vincent’s Hospital in Melbourne, Australia, are leading the research....
International Edition